Tenaya Therapeutics Announces Interim Data from MyPEAK™-1 Showing Treatment of MYBPC3-associated HCM with TN-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Sym
Go back to Tenaya Therapeutics Announces Interim Data from MyPEAK™-1 Showing Treatment of MYBPC3-associated HCM with TN-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Sym| (NASDAQ: TNYA) | Delayed: 0.70 -0.03 (4.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.73 | 52 Week High | $ | |||
| Open | $0.72 | 52 Week Low | $ | |||
| Day High | $0.73 | P/E | N/A | |||
| Day Low | $0.70 | EPS | $ | |||
| Volume | 2,036,489 | |||||
